Global Medical REIT

GMRE

Market cap $423M

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that it intends to release its third quarter 2025 financial results after the market closes on Tuesday, November 4, 2025. The Company intends to hold a conference call to discuss those results the following day, Wednesday, November 5, 2025, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief Financial Officer.

U.S. equity markets tumbled in a sudden jolt of volatility as investors - already flying blind on key data - reacted to a surprise, massive tariff announcement on Chinese imports. The White House announced a 100% added tariff on all Chinese imports beginning next month - up from 30% currently - as retaliation to new export controls on rare minerals. The CBOE Volatility Index surged to the highest levels since mid-May in a sudden onset of angst following several months of relatively tranquil market conditions.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that it entered into an amended and restated credit facility (the “Amended and Restated Credit Facility”) that extends the maturities of its borrowings and, among other things, includes the following terms: Extends the initial maturity date of the existing $400 million revolver component of the credit facility to October 2029 with two, six-month extension options available at the Comp.

Global Medical REIT remains a Buy, offering a solid business and attractive ~8.9% yield even after a significant dividend cut. GMRE's near-term catalysts include likely debt refinancing, potential rate cuts, and a $50M share buyback program to boost shareholder value. The company reaffirmed 2025 AFFO guidance and stands to benefit significantly from lower interest rates, supporting future dividend growth.

Insider purchases can be a great indicator to identify opportunities. REIT executives have been buying a lot of shares lately. I highlight two REITs with multi-million-dollar insider buys.

Global Medical REIT is paying out a just under 9% dividend yield to its common shareholders, which is now fully covered by FFO following a 29% cut in May. The REIT engineered a one-for-five reverse stock split last month, following a second quarter that saw FFO growth come in flat. With a weighted average interest rate of 4.09% on its debt and a term of 1.6 years, GMRE faces intense refinancing risk.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) announced today that it has completed the previously announced one-for-five reverse stock split (the “Reverse Stock Split”) of its issued, outstanding and authorized shares of common stock, par value $0.001 per share (the “Common Stock”), effective at 5:00 p.m., Eastern Time today (the “Effective Time”). Accordingly, at the Effective Time, every five issued and outstanding shares of Common Stock were.

REIT dividend yields are historically high. Many are offering 7%-12% dividend yields. I present three of my top picks in this yield range.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) announced today that its Board of Directors (“Board”) has declared the Company's 2025 third quarter common and preferred dividends. Common Dividend The Board has declared the Company's 2025 third quarter cash dividend of $0.75 per share of common stock and unit (the “Common Dividend”). The Common Dividend is payable on October 15, 2025, to common stockholders and unitholders of record as of September.

GMRE is a small-cap healthcare REIT with operational challenges, recently cutting its dividend by 29% due to financial pressures and stagnant growth. Despite undervaluation metrics, I see the discount as justified given weak fundamentals, high payout ratios, and limited growth prospects in a tough real estate market. Recent results show some operational improvement, but debt levels, high payout ratios, and exposure to interest rate risk remain significant concerns.